Shiff Susan Ph.D.

Shiff Susan Ph.D. is listed in filings as Director at Tvardi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 21, 2025, including 1 public disclosure. Recent filings connect the profile to Tvardi Therapeutics, Inc. (TVRD). The current snapshot covers public activity from Apr 21, 2025. Reported amounts are shown as $204.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.